FEATURED ARTICLES

Clinical News Roundup: FDA Updates Guidance On Race/Ethnicity
Clinical News Roundup: FDA Updates Guidance On Race/Ethnicity

Clinical news roundup for the week of October 31, 2016 with information on FDA guidance related to race and ethnicity in clinical trials, DIA’s patient engagement study, Parkinson’s Disease Foundation funding research, age and thyroid cancer treatments, and Merck’s success with Alzheimer’s disease.

  • Health Experts Weigh In On Zika Risks And Potential For Future Outbreaks
    Health Experts Weigh In On Zika Risks And Potential For Future Outbreaks

    With the Zika virus spreading in the Americas, the outbreak and potential for future outbreaks in other areas of the world has many health professionals and organizations concerned. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID), which promotes research, risk assessment, knowledge sharing, and best practices in the fight against infectious diseases, is one of those organizations.

More Featured Articles

WHITE PAPERS & CASE STUDIES

  • SynteractHCR Full-Service CRO Brochure

    SynteractHCR is a multinational clinical research organization, formed from the merger of Synteract with Harrison Clinical Research in 2013, which provides global, full-service clinical trial services. We have more than two decades of experience supporting biopharma companies in all phases of clinical development across multiple therapeutic areas. We customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.

  • Improve Accuracy And Efficiency In Data Collection For Mental-Health Evaluations And Assessments

    MedAvante is a global provider of centralized, expert psychological rating services to the pharmaceutical, biotechnology, and medical device industries.

  • Phase II Alzheimer's Case Study

    A double-blind, Phase II, placebo-controlled clinical trial to evaluate the safety and efficacy of a novel compound in subjects with mild to moderate Alzheimer’s disease.

  • Moving Towards An Electronic Environment In Clinical Trials

    With each passing year, clinical trials are becoming increasingly global. The business of product development is moving away from the traditional model in which studies are conducted primarily in the US – in fact, recent estimates indicate that within the next three years, up to 65 per cent of studies under FDA regulation will be conducted outside the US. A review of a US government clinical trials registry and of 300 published reports in major medical journals revealed that one third (157 of 509) of Phase III trials were being conducted entirely outside the US, with over half the study sites (13,521 of 24,206) used in these trials located overseas, many in eastern Europe and Asia.

  • Brochure: Norwich Clinical Services

    Norwich Clinical Services is a contract research organization that provides Bioanalytical Services, Pharmacovigilance and Clinical Research Programs to the pharmaceutical and biotech industries.

  • Oncology Medical Imaging Expertise Sheet

    In oncology, there are many imaging endpoints based on the assessment of tumor size or function. These endpoints include disease-free survival, objective response rate, time to progression, progression-free survival and time to treatment failure. 

More White Papers & Case Studies

SERVICES & PRODUCTS

CRISTal - Clinical Research Interactive Selection Tool       CRISTal - Clinical Research Interactive Selection Tool

CRISTal is RDP Clinical Outsourcing’s proprietary software platform that facilitates the strategic identification of sites, as well as our highly experienced regional monitors.

Imaging Core Lab Services Imaging Core Lab Services

ICON Medical Imaging’s use of superior technology, advanced science and experienced people lead to the ultimate goal: results.

Trial Management For Diagnostic Imaging Agents Trial Management For Diagnostic Imaging Agents

ICON Medical Imaging specialises in clinical trials that involve imaging as a primary endpoint. Our senior management team has performed hundreds of imaging trials over the past twenty years

Point Of Care Solutions For Pharmaceutical Clinical Trials Point Of Care Solutions For Pharmaceutical Clinical Trials
Blinded Diagnostics is a contract service organization specializing in same day lab test results using point-of-care diagnostic platforms to optimize patient enrollment testing, blinded studies, adaptive trials and remote patient testing.
Point Of Care: Neurological Testing Point Of Care: Neurological Testing
Blinded Diagnostics offers ambulatory EEG for neurological tests which are typically performed at the point of care
Point Of Care: Drug Abuse Testing Point Of Care: Drug Abuse Testing
Point of care drugs of abuse tests include Methadone, Opiates, THC and Amphetamines for screening and has available results in minutes.
More Services & Products

NEWS

More News